Fast-tracking the use of copper in the NHS to tackle AMR

  22 January 2021

Rory Donnelly, clinical research director of Copper Clothing, discusses the need to fast track copper for use in the NHS as an antimicrobial material in light of the rapid roll out of COVID-19 vaccines.

COVID-19 has pushed the topic of public health to the forefront of people’s minds. From the outset, the question on everyone’s lips was, “when will we get a vaccine?”. Now that has been answered, we have seen COVID-19 vaccines rolled out at record speed, requiring immense collaborative efforts across the medical sector to ensure they can be supplied to the population as quickly and as safely as possible. But other medical innovations have not enjoyed this same experience.

Further reading: Health Europe
Author(s): Rory Donnelly
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!